These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
699 related items for PubMed ID: 24041465
21. Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan. Lin SH, Liao WH, Lai CC, Liao CH, Tan CK, Wang CY, Huang YT, Hsueh PR. J Antimicrob Chemother; 2010 Aug; 65(8):1792-8. PubMed ID: 20511366 [Abstract] [Full Text] [Related]
23. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia. Song KH, Kim HB, Kim HS, Lee MJ, Jung Y, Kim G, Hwang JH, Kim NH, Kim M, Kim CJ, Choe PG, Chung JY, Park WB, Kim ES, Park KU, Kim NJ, Kim EC, Oh MD. Int J Antimicrob Agents; 2015 Dec; 46(6):689-95. PubMed ID: 26555059 [Abstract] [Full Text] [Related]
27. Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK context. Hope R, Blackburn RM, Verlander NQ, Johnson AP, Kearns A, Hill R, Hopkins S, Sheridan E, Livermore DM, Vancomycin Outcome Study Group, UK Clinical Infection Research Group. J Antimicrob Chemother; 2013 Nov; 68(11):2641-7. PubMed ID: 23794604 [Abstract] [Full Text] [Related]
29. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ. Clin Infect Dis; 2012 Jan 01; 54(1):51-8. PubMed ID: 22109947 [Abstract] [Full Text] [Related]
30. Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey. Sancak B, Yagci S, Gür D, Gülay Z, Ogunc D, Söyletir G, Yalcin AN, Dündar DO, Topçu AW, Aksit F, Usluer G, Ozakin C, Akalin H, Hayran M, Korten V. BMC Infect Dis; 2013 Dec 10; 13():583. PubMed ID: 24325260 [Abstract] [Full Text] [Related]
31. Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia. Hegde SS, Skinner R, Lewis SR, Krause KM, Blais J, Benton BM. J Antimicrob Chemother; 2010 Apr 10; 65(4):725-8. PubMed ID: 20139142 [Abstract] [Full Text] [Related]
36. In vitro evaluation of ceftaroline alone and in combination with tobramycin against hospital-acquired meticillin-resistant Staphylococcus aureus (HA-MRSA) isolates. Vidaillac C, Leonard SN, Rybak MJ. Int J Antimicrob Agents; 2010 Jun 10; 35(6):527-30. PubMed ID: 20346632 [Abstract] [Full Text] [Related]